SARCOMA - Cancer proteome, tumor vs adjacent non-tumor (ProteinTalks DB, GIST)
Number of samples
50 (25 tumor / adjacent non-tumor pairs)
Detected in
25/25 tumors, 15/25 non-tumors
Tumor vs non-tumor
Up in tumor (log2FC 0.76, adj. p-value 3.87e-4)
Samples
Patient ID
Tumor
Non-tumor
GIST_04
10.9
9.7
GIST_05
10.7
9.3
GIST_01
10.6
N/A
GIST_11
10.6
9.9
GIST_02
10.6
N/A
GIST_03
10.6
8.8
GIST_16
10.3
N/A
GIST_23
10.3
N/A
GIST_07
10.2
N/A
GIST_13
10.1
8.3
GIST_14
10.1
N/A
GIST_09
10.1
9.3
GIST_20
10.1
9.7
GIST_15
9.9
8.7
GIST_21
9.9
N/A
GIST_08
9.9
10.0
GIST_22
9.8
8.8
GIST_24
9.7
N/A
GIST_18
9.7
N/A
GIST_25
9.7
9.8
GIST_06
9.7
8.7
GIST_19
9.6
9.7
GIST_12
9.6
9.2
GIST_10
9.4
N/A
GIST_17
9.2
8.7
Show allShow less
SARCOMA - Cancer proteome, tumor vs adjacent non-tumor (ProteinTalks DB, MUT)
Number of samples
48 (24 tumor / adjacent non-tumor pairs)
Detected in
21/24 tumors, 9/24 non-tumors
Tumor vs non-tumor
Not significant (log2FC 0.05, adj. p-value 9.21e-1)
Samples
Patient ID
Tumor
Non-tumor
MUT_01
10.5
10.2
MUT_06
10.4
N/A
MUT_02
10.4
9.7
MUT_03
10.1
10.4
MUT_20
9.8
N/A
MUT_18
9.6
9.2
MUT_15
9.4
N/A
MUT_10
9.4
N/A
MUT_23
9.3
9.3
MUT_07
9.3
N/A
MUT_05
9.2
9.1
MUT_14
9.2
N/A
MUT_21
9.1
N/A
MUT_19
9.1
N/A
MUT_22
9.0
N/A
MUT_17
8.9
N/A
MUT_12
8.9
9.7
MUT_08
8.8
N/A
MUT_24
8.8
9.0
MUT_09
8.8
N/A
MUT_13
8.7
N/A
MUT_04
N/A
N/A
MUT_11
N/A
9.7
MUT_16
N/A
N/A
Show allShow less
We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.